Literature DB >> 22449225

CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension.

Keiko Ohta-Ogo1, Hiroyuki Hao, Hatsue Ishibashi-Ueda, Seiichi Hirota, Kazufumi Nakamura, Tohru Ohe, Hiroshi Ito.   

Abstract

Plexiform lesions in pulmonary arteries are a characteristic histological feature for idiopathic pulmonary arterial hypertension (IPAH). The pathogenesis of the plexiform lesion is not fully understood, although it may be related to endothelial cell dysfunction and local inflammation. CD44 is a cell adhesion molecule and it is also involved in angiogenesis, endothelial cell proliferation and migration. The expression of CD44 was examined in lung plexiform lesions obtained from patients with IPAH (IPAH group, n= 7) and pulmonary arterial hypertension associated with atrial septal defect (ASD-PAH group, n= 4). Expression of CD44 was detected in 49 out of 52 plexiform lesions (93%) from all patients in the IPAH group, whereas 31 plexiform lesions obtained from the ASD-PAH group lacked CD44 positivity by immunohistochemistry. In the IPAH group, CD44 was localized in the endothelial cells of microvessels within plexiform lesions and activated T cells in and around the lesions. Furthermore, T cell infiltration and endothelial cell proliferation activity were prominent in the plexiform lesions of the IPAH group, compared to those of the ASD-PAH group. These findings suggest that CD44 and activated T cell infiltration play an important role in the development of plexiform lesions particularly in IPAH.
© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449225     DOI: 10.1111/j.1440-1827.2011.02779.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Modification of hyaluronan by heavy chains of inter-α-inhibitor in idiopathic pulmonary arterial hypertension.

Authors:  Mark E Lauer; Metin Aytekin; Suzy A Comhair; Jacqueline Loftis; Liping Tian; Carol F Farver; Vincent C Hascall; Raed A Dweik
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 2.  Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.

Authors:  Christian Michael Perez; Quentin Felty
Journal:  Microvasc Res       Date:  2022-02-07       Impact factor: 3.514

3.  Potential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion.

Authors:  Feng-Jin Shao; Xiao-Ling Guo; Jia-Xue Xu; Rui Liu; Dan-Yue Li; Qing-Hao Li; Ting Zhou; Cun Fang; Xun Tan
Journal:  Respir Res       Date:  2022-10-23

4.  A cancer amidst us: the plexiform lesion in pulmonary arterial hypertension.

Authors:  Ji Young Lee; C Michael Francis; Natalie N Bauer; Natalie R Gassman; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-19       Impact factor: 6.011

Review 5.  Signal transduction in the development of pulmonary arterial hypertension.

Authors:  Simon Malenfant; Anne-Sophie Neyron; Roxane Paulin; François Potus; Jolyane Meloche; Steeve Provencher; Sébastien Bonnet
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

6.  Role of miR-223-3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway.

Authors:  Aijun Liu; Yifan Liu; Bin Li; Ming Yang; Yang Liu; Junwu Su
Journal:  Cell Prolif       Date:  2018-12-03       Impact factor: 6.831

Review 7.  Cardiovascular Effects Mediated by HMMR and CD44.

Authors:  Kinga Jaskuła; Mariusz Sacharczuk; Zbigniew Gaciong; Dominik S Skiba
Journal:  Mediators Inflamm       Date:  2021-07-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.